Cart
sales@molnova.com
GSK 789472 hydrochloride
CAS No. 1257326-24-1
GSK 789472 hydrochloride( 4,5-Dihydro-1-phenyl-3-(2-piperidinyl)methylimidazol-2(1H)-one | 1-phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride | GSK-789472 HCl )
Catalog No. M27633 CAS No. 1257326-24-1
GSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 161 | In Stock |
|
| 10MG | 230 | In Stock |
|
| 25MG | 530 | In Stock |
|
| 50MG | 755 | In Stock |
|
| 100MG | 1044 | In Stock |
|
| 500MG | 2097 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK 789472 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.
-
DescriptionGSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.
-
In Vitro——
-
In Vivo——
-
Synonyms4,5-Dihydro-1-phenyl-3-(2-piperidinyl)methylimidazol-2(1H)-one | 1-phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride | GSK-789472 HCl
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1257326-24-1
-
Formula Weight295.81
-
Molecular FormulaC15H22ClN3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=C1N(CC2CCCCN2)CCN1c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moon JM, Chun BJ. Clinical characteristics of patients after dicamba herbicide ingestion. Clin Toxicol (Phila). 2014 Jan;52(1):48-53.
molnova catalog
related products
-
A-68930 hydrochlorid...
A-68930 is a potent, specific, orally bioavailable agonist of the D1 Dopamine receptor with EC50 of 2.5 nM.
-
ABT-724
ABT-724 is an agonist of dopamine D4 receptor(EC50: 12.4 nM).
-
Miriplatin
Miriplatin (SM-11355) is a platinum complex used in TACE that has promise for the therapy of hepatocellular carcinoma (HCC).
